GB1385086A - Insulin product - Google Patents

Insulin product

Info

Publication number
GB1385086A
GB1385086A GB1974172A GB1974172A GB1385086A GB 1385086 A GB1385086 A GB 1385086A GB 1974172 A GB1974172 A GB 1974172A GB 1974172 A GB1974172 A GB 1974172A GB 1385086 A GB1385086 A GB 1385086A
Authority
GB
United Kingdom
Prior art keywords
insulin
alkali metal
protamine
salt
aqueous medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1974172A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of GB1385086A publication Critical patent/GB1385086A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
GB1974172A 1971-04-30 1972-04-28 Insulin product Expired GB1385086A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13912071A 1971-04-30 1971-04-30

Publications (1)

Publication Number Publication Date
GB1385086A true GB1385086A (en) 1975-02-26

Family

ID=22485216

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1974172A Expired GB1385086A (en) 1971-04-30 1972-04-28 Insulin product

Country Status (23)

Country Link
US (1) US3758683A (enrdf_load_html_response)
JP (1) JPS5735185B1 (enrdf_load_html_response)
BE (1) BE782651A (enrdf_load_html_response)
CA (1) CA976085A (enrdf_load_html_response)
CH (1) CH566784A5 (enrdf_load_html_response)
CS (1) CS209458B2 (enrdf_load_html_response)
DD (1) DD100708A5 (enrdf_load_html_response)
DE (1) DE2219635C3 (enrdf_load_html_response)
DK (1) DK131760C (enrdf_load_html_response)
ES (1) ES402176A1 (enrdf_load_html_response)
FI (1) FI49773C (enrdf_load_html_response)
FR (1) FR2134658B1 (enrdf_load_html_response)
GB (1) GB1385086A (enrdf_load_html_response)
HU (1) HU166989B (enrdf_load_html_response)
IL (1) IL39181A (enrdf_load_html_response)
NL (1) NL178258C (enrdf_load_html_response)
NO (1) NO137178C (enrdf_load_html_response)
PL (1) PL86966B1 (enrdf_load_html_response)
RO (1) RO64387A (enrdf_load_html_response)
SE (1) SE378066B (enrdf_load_html_response)
SU (1) SU508162A3 (enrdf_load_html_response)
YU (1) YU36155B (enrdf_load_html_response)
ZA (1) ZA722243B (enrdf_load_html_response)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK140801B (da) * 1975-01-15 1979-11-19 Nordisk Insulinlab Fremgangsmåde til fremstilling af et stabilt langtidsvirkende insulinpræparat.
NL193099C (nl) * 1981-10-30 1998-11-03 Novo Industri As Gestabiliseerde insuline-oplossing.
JPH01501389A (ja) * 1986-10-20 1989-05-18 ノボ インダストリ アクティーゼルスカブ ポリペプチド製剤
DE3880346T2 (de) * 1987-02-25 1993-07-29 Novonordisk As Insulinderivate.
DE19726167B4 (de) * 1997-06-20 2008-01-24 Sanofi-Aventis Deutschland Gmbh Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
US6624141B1 (en) 1999-03-17 2003-09-23 The Regents Of The University Of Michigan Protamine fragment compositions and methods of use
DE10114178A1 (de) * 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) * 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
KR20110084956A (ko) 2008-10-17 2011-07-26 사노피-아벤티스 도이칠란트 게엠베하 인슐린과 glp-1 효능제의 병용물
PL3417871T3 (pl) 2009-11-13 2021-06-14 Sanofi-Aventis Deutschland Gmbh Kompozycja farmaceutyczna zawierająca agonistę GLP-1, insulinę i metioninę
BR112012011403B8 (pt) 2009-11-13 2021-05-25 Sanofi Aventis Deutschland composição farmacêutica líquida compreendendo um agonista glp-1 e metionina e uso da mesma
MX339614B (es) 2010-08-30 2016-06-02 Sanofi - Aventis Deutschland GmbH Uso de ave0010 para la fabricacion de un medicamento para el tratamiento de la diabetes mellitus tipo 2.
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
CA2846413C (en) 2011-08-29 2021-11-02 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for use in glycemic control in diabetes type 2 patients
AR087744A1 (es) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
SG11201704678SA (en) 2014-12-12 2017-07-28 Sanofi Aventis Deutschland Insulin glargine/lixisenatide fixed ratio formulation
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患之治療
TWI847306B (zh) 2017-08-24 2024-07-01 丹麥商諾佛 儂迪克股份有限公司 Glp-1組成物及其用途
BR112022013795A2 (pt) 2020-02-18 2022-09-13 Novo Nordisk As Composição farmacêutica líquida, e, kit

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5038E (fr) * 1904-03-09 1905-12-02 Georges Frederic Brade Perfectionnements dans la fabrication des organes du métronome
GB889769A (en) * 1957-07-18 1962-02-21 Nordisk Insulinlab Slowly acting insulin preparation in crystalline form

Also Published As

Publication number Publication date
US3758683A (en) 1973-09-11
SE378066B (enrdf_load_html_response) 1975-08-18
RO64387A (fr) 1979-07-15
YU36155B (en) 1982-02-25
FR2134658B1 (enrdf_load_html_response) 1975-10-17
CS209458B2 (en) 1981-12-31
CA976085A (en) 1975-10-14
FI49773B (enrdf_load_html_response) 1975-06-30
ES402176A1 (es) 1975-03-01
HU166989B (enrdf_load_html_response) 1975-07-28
YU114272A (en) 1981-06-30
ZA722243B (en) 1973-11-28
FI49773C (fi) 1975-10-10
NO137178C (no) 1978-01-18
DD100708A5 (enrdf_load_html_response) 1973-10-05
IL39181A (en) 1974-09-10
NL7205865A (enrdf_load_html_response) 1972-11-01
CH566784A5 (enrdf_load_html_response) 1975-09-30
DE2219635C3 (de) 1981-10-15
NL178258B (nl) 1985-09-16
IL39181A0 (en) 1972-06-28
DE2219635A1 (de) 1972-11-09
NL178258C (nl) 1986-02-17
BE782651A (fr) 1972-10-26
DK131760C (da) 1976-02-02
JPS5735185B1 (enrdf_load_html_response) 1982-07-27
PL86966B1 (enrdf_load_html_response) 1976-06-30
DK131760B (da) 1975-09-01
SU508162A3 (ru) 1976-03-25
FR2134658A1 (enrdf_load_html_response) 1972-12-08
NO137178B (no) 1977-10-10
DE2219635B2 (de) 1980-11-27

Similar Documents

Publication Publication Date Title
GB1385086A (en) Insulin product
GB1466153A (en) Treatment of diarrhea in mammals
GB1469862A (en) Therapeutic compositions containing etherified monosaccharide derivatives and method of using the same
GB1427243A (en) Process for the preparation of manganese ethylene bisdithio carbamate products and fungicidal compositions containing the products prepared in this way
GB921077A (en) Production of precipitated calcium carbonate
GB1256968A (enrdf_load_html_response)
GB1422193A (en) Pharmaceutical compositions
SU464087A3 (ru) Способ получени суспензии гонадотропинов
GB748024A (en) Improved therapeutic preparations of iron
GB1165098A (en) Improvements in the Preparation of Chlorine-Producing Bactericidal Compositions
GB1451352A (en) Method of suppressing mildew using a composition containing an alkanoic acid salt
GB1518519A (en) Production of silver powders
GB1415453A (en) Composition and process for producing aquarium water having improved properties
GB1170318A (en) Improvements in or relating to Inhibiting the Discolouration of Egg White
GB1382008A (en) Fungicidal and/or bacterial composition and method
ES351689A1 (es) Un procedimiento de praparacion de una composicion seca, delibre fluencia no higroscopica, que contiene cloruro de co- lina.
GB1184754A (en) Electrolytic Hydrodimerisation Process
GB1313164A (en) Blood plasma substitute
GB889769A (en) Slowly acting insulin preparation in crystalline form
GB1348798A (en) Process for the production of citric acid by submerged fermentation
GB1342311A (en) Process for the production of citric acid by submerged fer mentation
GB1237309A (en) Stabilising aqueous solutions of potassium persulphate
GB1389406A (en) Powdered alkali metal borogluco-heptonates
GB748857A (en) Process for the making of adrenocorticotrophin (acth) preparations having a prolonged action from acth with high specific activity
ES275159A1 (es) Un proceso industrial de fermentaciën continua de acido lactico

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee